← Open Payments lookup

PAULA QUATTLEBAUM: Open Payments

NPI 1487376935 · MALVERN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$272 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $272

Food & beverage: $272
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.4$68
Neurocrine BioSciences, Inc.3$60
Otsuka America Pharmaceutical, Inc.2$47
Axsome Therapeutics, Inc.1$35
Takeda Pharmaceuticals U.S.A., Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Janssen Pharmaceuticals, Inc1$19

Products named: INGREZZA, FANAPT, Auvelity, ABILIFY MAINTENA, TRINTELLIX, REXULTI, CAPLYTA, HETLIOZ.

Industry payments across AR — which companies pay providers there.